Literature DB >> 14636896

Cytosolic p21Waf1/Cip1 increases cell cycle transit in vascular smooth muscle cells.

Yao Dong1, Sylvia L Chi, Alexander D Borowsky, Yaping Fan, Robert H Weiss.   

Abstract

The intracellular localization of signaling proteins is critical in directing their interactions with both upstream and downstream signaling cascade components. While initially described as a cyclin kinase inhibitor, p21Waf1/Cip1 has since been shown to have bimodal effects on cell cycle progression and cell proliferation, and evidence is emerging that intracellular localization of this protein plays a role in directing its signaling properties by dictating its interactions with downstream molecules. Since we have previously demonstrated a pro-apoptotic and cell cycle inhibitory effect of p21 attenuation after transfection of antisense p21 oligodeoxynucleotides (ODN) in several cell lines, we asked whether cytosolic p21 mediates a positive effect on vascular smooth muscle (VSM) cell cycle transit. We now show that transfection of a nuclear-localization signal deficient (DeltaNLS) p21 construct into VSM cells results in increased cytosolic levels of p21 and causes increased cell cycle transit as measured by [3H]thymidine incorporation. Thus, at least in VSM cells, cytosolic localization of p21 is a means by which this signaling protein transmits pro-mitogenic signals to the proteins responsible for G1/S transition. Furthermore, compartmentalization of p21 may help explain the biphasic nature of p21 in a variety of cell types and may lead to therapeutic advances directed at modulating pathologic cell growth in vascular diseases and cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14636896     DOI: 10.1016/s0898-6568(03)00136-0

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  14 in total

1.  Heme oxygenase-1 induced by aprotinin inhibits vascular smooth muscle cell proliferation through cell cycle arrest in hypertensive rats.

Authors:  Hyoung Chul Choi; Kwang Youn Lee; Dong Hyup Lee; Young Jin Kang
Journal:  Korean J Physiol Pharmacol       Date:  2009-08-31       Impact factor: 2.016

2.  A novel p21 attenuator which is structurally related to sorafenib.

Authors:  Hiromi I Wettersten; Sung Hee Hwang; Cuiwen Li; Eunice Y Shiu; Aaron T Wecksler; Bruce D Hammock; Robert H Weiss
Journal:  Cancer Biol Ther       Date:  2013-01-08       Impact factor: 4.742

3.  Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy.

Authors:  Hiromi Inoue; Sung Hee Hwang; Aaron T Wecksler; Bruce D Hammock; Robert H Weiss
Journal:  Cancer Biol Ther       Date:  2011-11-01       Impact factor: 4.742

4.  Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts.

Authors:  Stephen E Mercer; Daina Z Ewton; Xiaobing Deng; Seunghwan Lim; Thomas R Mazur; Eileen Friedman
Journal:  J Biol Chem       Date:  2005-04-25       Impact factor: 5.157

5.  Tyrosine phosphorylation of the p21 cyclin-dependent kinase inhibitor facilitates the development of proneural glioma.

Authors:  Ellen Hukkelhoven; Yuhui Liu; Nancy Yeh; Daniel Ciznadija; Stacy W Blain; Andrew Koff
Journal:  J Biol Chem       Date:  2012-09-24       Impact factor: 5.157

6.  A novel, non-apoptotic role for Scythe/BAT3: a functional switch between the pro- and anti-proliferative roles of p21 during the cell cycle.

Authors:  Sheila T Yong; Xiao-Fan Wang
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

7.  Pathway analysis of kidney cancer using proteomics and metabolic profiling.

Authors:  Bertrand Perroud; Jinoo Lee; Nelly Valkova; Amy Dhirapong; Pei-Yin Lin; Oliver Fiehn; Dietmar Kültz; Robert H Weiss
Journal:  Mol Cancer       Date:  2006-11-24       Impact factor: 27.401

8.  Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance.

Authors:  Pei-Yin Lin; Susan P Fosmire; See-Hyoung Park; Jin-Young Park; Shairaz Baksh; Jaime F Modiano; Robert H Weiss
Journal:  Mol Cancer       Date:  2007-02-14       Impact factor: 27.401

9.  Modulation of expression and cellular distribution of p21 by macrophage migration inhibitory factor.

Authors:  Elliott Taranto; Jin R Xue; Eric F Morand; Michelle Leech
Journal:  J Inflamm (Lond)       Date:  2009-08-24       Impact factor: 4.981

10.  Id1 restrains p21 expression to control endothelial progenitor cell formation.

Authors:  Alessia Ciarrocchi; Vladimir Jankovic; Yuval Shaked; Daniel J Nolan; Vivek Mittal; Robert S Kerbel; Stephen D Nimer; Robert Benezra
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.